DFDADECENTRALIZED FRAMEWORK FOR DRUG ASSESSMENT

Liver Transplantation

Treatment used for 5 conditions

Total Trials
6,055
Total Participants
368K
Avg Effectiveness
91%
Avg Safety Score
30%

Conditions Treated

Click on a condition to view detailed treatment information and clinical trial data.

Liver cancer due to NASH
Effectiveness:95%
Safety:25%
Trials:5,000
Participants:200K
Liver cancer due to hepatitis C
Effectiveness:95%
Safety:40%
Trials:500
Participants:100K
Liver cancer due to alcohol use
Effectiveness:90%
Safety:35%
Trials:500
Participants:50K
Liver cancer due to hepatitis B
Effectiveness:95%
Safety:25%
Trials:50
Participants:10K
Hepatoblastoma
Effectiveness:80%
Safety:25%
Trials:5
Participants:8K
DECENTRALIZED FRAMEWORK FOR DRUG ASSESSMENT

EVIDENCE-BASED TREATMENT INFORMATION

TREATMENTS

  • CONDITIONS
  • TREATMENTS
  • FIND TRIALS

ABOUT

  • ABOUT
  • RESEARCH & EVIDENCE
  • FAQ

CONTACT

hello@dfda.earth
dFDA.earth

EVIDENCE-BASED TREATMENT INFORMATION

PRIVACY POLICY•TERMS OF SERVICE
© 2025 Mike P. Sinn